- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04228549
MyPADMGT Support of Out-Patients With Peripheral Arterial Disease (Final_PADHSS)
April 21, 2023 updated by: McMaster University
My Peripheral Arterial Disease Management (MyPADMGT) Support of Out-Patients With Peripheral Arterial Disease
The investigators have developed an online program to help people with peripheral arterial disease (PAD) in their extremities to better self-manage their condition.
Some earlier testing has been done and the investigators now wish to try this system with participants who have this blood vessel disease as well as high blood pressure.
Investigators are hoping to help these participants to achieve healthier lifestyles and improve their quality of life through education, monitoring and continuing support.
A similar online desk-top version with over 30 participants has been tested at St. Michael's Hospital in Toronto.
The investigators propose to test this newer mobile system with 210 outpatient participants from Hamilton General Hospital.
Data collected will be analyzed following the (12 months for each participant) study, along with data recorded during clinical visits at baseline and twelve months for each participant.
The objective is to evaluate changes to participant health and determine whether the health self-management process has been successful in improving participant lifestyles and quality of life, when compared to usual care.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
126
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N3Z5
- General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Out-patients with Peripheral Arterial Disease (Ankle Brachial Index < 0.90)
- Attending the Hamilton General Hospital Outpatient Vascular Clinic
- May be living alone or with one or more caregivers
- Must have Internet access.
Exclusion Criteria:
- Age < 18 years
- Not diagnosed with PAD
- Unable to communicate in English
- Unwilling to participate
- Patients with dementia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Usual care
|
|
|
Experimental: MyPADMGT
Online access to system, with ability to record and study progress with social interaction, diet, physical activity, smoking cessation, blood glucose, blood pressure and weight.
Also access to educational content, journal recording, communication to others, setting target levels, contact support as needed.
|
Online tracking and feedback to help patients adopt healthy lifestyles
|
|
Experimental: MyPADMGT + Nudging
Online access to system, with ability to record and study progress with social interaction, diet, physical activity, smoking cessation, blood glucose, blood pressure and weight.
Also access to educational content, journal recording, communication to others, setting target levels, contact support as needed.
In addition, nudging support available to help patients make better choices and decisions.
|
Online tracking and feedback to help patients adopt healthy lifestyles plus nudging support to assist in making decisions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Systolic Blood Pressure
Time Frame: 1 Year
|
Change in systolic blood pressure measured in clinic by blood pressure cuff
|
1 Year
|
|
EQ-5D-5L Quality of Life Visual Result
Time Frame: 1 Year
|
Change in QoL Visual Result measured by questionnaire.
Min = 0, Max = 100.
Higher outcome scores are better
|
1 Year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ankle Brachial Index
Time Frame: 1 year
|
Change in Ankle Brachial Index as measured in the clinic.
Higher outcome scores are better
|
1 year
|
|
Body Weight
Time Frame: 1 year
|
Change in Body Mass Index towards normal healthy range.
Adult healthy minimum is 18.5 and healthy maximum is 24.9
|
1 year
|
|
Social Isolation
Time Frame: 1 year
|
Change in Friendship Scale as measured by Hawthorne Friendship Scale Questionnaire.
Min.
= 0; Max.
= 24.
Higher outcome scores are better
|
1 year
|
|
Smoking Cessation
Time Frame: 1 year
|
Smoking Cessation by Smokers as self-reported by Smokers.
More Cessations is better
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael Stacey, MD, McMaster University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 24, 2021
Primary Completion (Actual)
June 30, 2022
Study Completion (Actual)
June 30, 2022
Study Registration Dates
First Submitted
January 10, 2020
First Submitted That Met QC Criteria
January 10, 2020
First Posted (Actual)
January 14, 2020
Study Record Updates
Last Update Posted (Actual)
April 25, 2023
Last Update Submitted That Met QC Criteria
April 21, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8108
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
Marissa JarosinskiTerminatedPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
OrbusNeichEucatech AG; Centre Européen de Recherche CardiovasculaireRecruitingPeripheral Arterial Disease | Peripheral Arterial Occlusive DiseaseSpain, Singapore, Belgium, Germany
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
BayerCompleted
-
Wroclaw Medical UniversityPoznan University of Medical Sciences; Military Institute of Medicine National...RecruitingPeripheral Arterial Disease(PAD)Poland
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Peripheral Artery Occlusive DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland